Cellular and molecular mechanisms of cartilage damage and repair

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1172-1177

  Sherwood, Joanna C ^a   Bertrand, Jessica ^a   Eldridge, Suzanne E ^a   Dell'accio, Francesco ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ARTHRITIS; ARTICULAR CARTILAGE; AUTOPHAGY; BONE DESTRUCTION; BONE DEVELOPMENT; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE INJURY; CARTILAGE REPAIR; CELL DEATH; CELL FUNCTION; CELL TYPE; CELLULAR MECHANISM; CHONDROGENESIS; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; INFLAMMATION; MECHANICAL STRESS; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; REVIEW; TISSUE REGENERATION; TISSUE REPAIR; WNT SIGNALING PATHWAY; ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS; WOUND HEALING;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE; CHONDROCYTES; HUMANS; INFLAMMATION; OSTEOARTHRITIS; WOUND HEALING;

EID: 84906316012     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.05.014     Document Type: Review

References (94)

1. M.B. Goldring, and S.R. Goldring Osteoarthritis J. Cell Physiol. 213 2007 626 634
2. H. Stanton et al. Proteoglycan degradation by the ADAMTS family of proteinases Biochim. Biophys. Acta 1812 2011 1616 1629
3. F. Dell'accio, and T.L. Vincent Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions Eur. Cell. Mater. 20 2010 210 217
4. N.M. Eltawil et al. A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury Osteoarthritis Cartilage 17 2009 695 704
5. S.S. Glasson In vivo osteoarthritis target validation utilizing genetically-modified mice Curr. Drug Targets 8 2007 367 376
6. C.B. Little et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair J. Clin. Invest. 117 2007 1627 1636
7. S.S. Glasson et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis Nature 434 2005 644 648
8. H. Stanton et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro Nature 434 2005 648 652
9. P.S. Chockalingam et al. Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor Osteoarthritis Cartilage 19 2011 315 323
10. M. Shiozaki et al. Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1- sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors J. Med. Chem. 54 2011 2839 2863
11. S.C. De et al. Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis Biorg. Med. Chem. Lett. 21 2011 3301 3306
12. H. Deng et al. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT) J. Med. Chem. 55 2012 7061 7079
13. F. Echtermeyer et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis Nat. Med. 15 2009 1072 1076
14. J. Wang et al. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc J. Biol. Chem. 286 2011 39738 39749
15. S. Sutton et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis Vet. J. 179 2009 10 24
16. A.K. Rosenthal Crystals, inflammation, and osteoarthritis Curr. Opin. Rheumatol. 23 2011 170 173
17. J.B. Fitzgerald et al. Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP J. Biol. Chem. 279 2004 19502 19511
18. J.H. Lee et al. Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression Arthritis Rheum. 52 2005 2386 2395
19. J. Gruber et al. Induction of interleukin-1 in articular cartilage by explantation and cutting Arthritis Rheum. 50 2004 2539 2546
20. V. Krenn et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis Histopathology 49 2006 358 364
21. T. Saxne et al. Inflammation is a feature of the disease process in early knee joint osteoarthritis Rheumatology 42 2003 903 904
22. F.M. Brennan, and I.B. McInnes Evidence that cytokines play a role in rheumatoid arthritis J. Clin. Invest. 118 2008 3537 3545
23. J.L. Nam et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA Ann. Rheum. Dis. 69 2010 976 986
24. J. Sellam, and F. Berenbaum The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis Nat. Rev. Rheumatol. 6 2010 625 635
25. M.D. Smith et al. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis J. Rheumatol. 24 1997 365 371
26. F. Dell'accio et al. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis Arthritis Rheum. 58 2008 1410 1421
27. T. Aigner et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis Arthritis Rheum. 54 2006 3533 3544
28. T. Sato et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage Arthritis Rheum. 54 2006 808 817
29. V. Moos et al. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage J. Rheumatol. 26 1999 870 879
30. A.J. Fosang et al. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture Matrix 11 1991 17 24
31. T. Yasuda, and A.R. Poole A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway Arthritis Rheum. 46 2002 138 148
32. F.M. Rogerson et al. Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice Arthritis Rheum. 62 2010 3365 3373
33. M.B. Goldring et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes J. Clin. Invest. 94 1994 2307 2316
34. K.M. Clements et al. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy Arthritis Rheum. 48 2003 3452 3463
35. P.A. Guerne et al. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro J. Immunol. 144 1990 499 505
36. J.J. Nietfeld et al. Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage Arthritis Rheum. 33 1990 1695 1701
37. J.H. Ryu et al. Interleukin-6 plays an essential role in hypoxia-inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice Arthritis Rheum. 63 2011 2732 2743
38. M. Shinmei et al. The mechanism of cartilage degradation in osteoarthritic joints Semin. Arthritis Rheum. 19 1990 16 20
39. P. Silacci et al. Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity J. Biol. Chem. 273 1998 13625 13629
40. A.S. de Hooge et al. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging Osteoarthritis Cartilage 13 2005 66 73
41. F.A. van de Loo et al. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice Am. J. Pathol. 151 1997 177 191
42. J.P. Caron et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression Arthritis Rheum. 39 1996 1535 1544
43. X. Chevalier et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study Arthritis Rheum. 61 2009 344 352
44. N.E. Ponce et al. Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection Med. Microbiol. Immunol. 201 2012 145 155
45. D.E. Cressman et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice Science 274 1996 1379 1383
46. T. Vincent et al. Basic FGF mediates an immediate response of articular cartilage to mechanical injury Proc. Natl. Acad. Sci. U. S. A. 99 2002 8259 8264
47. F. Dell'accio et al. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury Arthritis Res. Ther. 8 2006 R139
48. T.L. Vincent et al. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer Osteoarthritis Cartilage 15 2007 752 763
49. S.L. Chia et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis Arthritis Rheum. 60 2009 2019 2027
50. N. Fukui et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes J. Bone Joint Surg. Am. 85A Suppl. 3 2003 59 66
51. R.J. Lories et al. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis J. Clin. Invest. 115 2005 1571 1579
52. R.J. Lories, and F.P. Luyten Bone morphogenetic protein signaling in joint homeostasis and disease Cytokine Growth Factor Rev. 16 2005 287 298
53. R.J. Lories et al. Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis Arthritis Rheum. 54 2006 1736 1746
54. J.M. Wozney, and H.J. Seeherman Protein-based tissue engineering in bone and cartilage repair Curr. Opin. Biotechnol. 15 2004 392 398
55. X. Yang et al. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage J. Cell Biol. 153 2001 35 46
56. M. Enomoto-Iwamoto et al. Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes J. Cell Biol. 140 1998 409 418
57. S.L. Adams et al. Stimulation of type-X collagen gene transcription by retinoids occurs in part through the BMP signaling pathway J. Bone Joint Surg. Am. 85A Suppl. 3 2003 29 33
58. S. Chubinskaya, and K.E. Kuettner Regulation of osteogenic proteins by chondrocytes Int. J. Biochem. Cell Biol. 35 2003 1323 1340
59. J.M. Wozney Overview of bone morphogenetic proteins Spine 27 2002 S2 S8
60. H.M. van Beuningen et al. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation Osteoarthritis Cartilage 6 1998 306 317
61. H.M. van Beuningen et al. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections Osteoarthritis Cartilage 8 2000 25 33
62. R. Serra et al. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis J. Cell Biol. 139 1997 541 552
63. R.B. Rountree et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage PLoS Biol. 2 2004 e355
64. J. Loughlin Genetics of osteoarthritis Curr. Genomics 23 2011 479 483
65. X. Guo et al. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation Genes Dev. 18 2004 2404 2417
66. C. Hartmann, and C.J. Tabin Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton Cell 104 2001 341 351
67. P.A. Beachy et al. Tissue repair and stem cell renewal in carcinogenesis Nature 432 2004 324 331
68. Y. Kawakami et al. Wnt/beta-catenin signaling regulates vertebrate limb regeneration Genes Dev. 20 2006 3232 3237
69. R. Yasuhara et al. Roles of beta-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells Lab. Invest. 91 2011 1739 1752
70. J. Loughlin et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females Proc. Natl. Acad. Sci. U. S. A. 101 2004 9757 9762
71. M. Enomoto-Iwamoto et al. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis Dev. Biol. 251 2002 142 156
72. M. Zhu et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice J. Bone Miner. Res. 24 2009 12 21
73. M. Zhu et al. Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction Arthritis Rheum. 58 2008 2053 2064
74. E. Koyama et al. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis Dev. Biol. 316 2008 62 73
75. R.J. Lories et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice Arthritis Rheum. 56 2007 4095 4103
76. D. Diarra et al. Dickkopf-1 is a master regulator of joint remodeling Nat. Med. 13 2007 156 163
77. G. Nalesso et al. WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways J. Cell Biol. 193 2011 551 564
78. H.A. Kestler, and M. Kuhl Generating a Wnt switch: it's all about the right dosage J. Cell Biol. 193 2011 431 433
79. N.R. Gough Understanding Wnt's role in osteoarthritis Sci. Signal. 4 2011 ec134
80. R. van Amerongen, and R. Nusse Towards an integrated view of Wnt signalling in development Development 136 2009 3205 3214
81. T. Saito et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development Nat. Med. 16 2010 678 686
82. S. Yang et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction Nat. Med. 16 2010 687 693
83. B. Carames et al. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis Arthritis Rheum. 62 2010 791 801
84. B. Carames et al. Mechanical injury suppresses autophagy regulators and its pharmacological activation results in chondroprotection Arthritis Rheum. 64 2011 1182 1192
85. B. Carames et al. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis Ann. Rheum. Dis. 71 2012 575 581
86. R. Lories The balance of tissue repair and remodeling in chronic arthritis Nat. Rev. Rheumatol. 7 2011 700 707
87. R.J. Lories, and F.P. Luyten The bone-cartilage unit in osteoarthritis Nat. Rev. Rheumatol. 7 2011 43 49
88. N. Bucay et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev. 12 1998 1260 1268
89. A. Kadri et al. Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis Arthritis Rheum. 58 2008 2379 2386
90. E.R. Sampson et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis Sci. Transl. Med. 3 2011 101ra93
91. K. Johnson et al. A stem cell-based approach to cartilage repair Science 336 2012 717 721
92. J.Y. Reginster et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial Ann. Rheum. Dis. 72 2013 179 186
93. J.P. Pelletier et al. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1beta in the synovium Ann. Rheum. Dis. 72 2013 250 257
94. D.G. Yu et al. Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model Acta Pharmacol. Sin. 34 2013 393 402